East Asia's Cell & Gene Therapy Landscape: Latest Advancements and Pipelines

Cell and Gene Therapy (CGT) is transforming the treatment landscape for cancer, rare diseases, and degenerative conditions. East Asia comprising of China, Japan, South Korea, and Taiwan has emerged as a global innovation hub, driven by:

  • Supportive regulatory frameworks
  • World-class clinical research
  • Growing Manufacturing capacity
  • Strong public–private investments

Download the e-Book HERE

East Asia's Cell & Gene Therapy Landscape: Latest Advancements and Pipelines

Complete the Form to Access the Webinar Video

Thank you! Click below to view/download:
Oops! Something went wrong while submitting the form.

Subscribe For News Updates

Subscribe to the IMAPAC Newsletter to stay informed of the latest news in the biopharmaceutical industry.

By clicking Sign Up you're confirming that you agree with our Privacy Policy.
Thank you! Your submission has been received!
Oops! Something went wrong while submitting the form.